fold induction of TCF activity compared to FOPflash

Curcumin has joined medical clinical trials at the stage I and clinical trial-level only in the last 10 15 years. A section IItudy of gem citabine, curcumin and celecoxib is a result of ready to accept generate ment at the Tel AviSourasky Infirmary for patients with metastatic colorectal cancer. Why curcumin GlcNAcstatin Curcumin is a part of turmeric, the yellow spice derived from the roots of the plant Curcuma longa. Curcuma longa is a short-stemmed perennial, which grows to about 100 cm high. It has circular leaves and oblong, ovate or round rhizomes. Curcuma longa grows naturally throughout the Indian subcontinent and in warm countries, especially South-east Asia. A traditional solution in Ayurvedic medicine and ancient Indian healing system that dates back over 5,000 years, turmeric is used through the ages as an herbal steroid and discomfort to alleviate disquiet and infection associated with an extraordinary spectral range of infectious and autoimmune diseases. Curcumin, Papillary thyroid cancer chemically it's called diferuloylmethane, has been the subject of a huge selection of pub lished documents within the last three years, studying its anti oxidant, anti dangerous, anti inflammatory, cancer chemopreventive and perhaps chemotherapeutic prop erties. The pharmacology and putative anti cancer properties of curcumin have been the subject of several review articles published since 1991, which pre-date numerous clinical reports of curcumin which have been completed and published within the past few years. But these properties do not prove the superiority of the phytochemical over other chemotherapeutic agents that also induced apoptosis effectively in cancer cells. Bulk of chemotherapeutic agents, including those iso lated from plants not just stimulate cancer cell apoptosis but also seriously damage the normal BMS-911543 cells of the host, the effects being particularly severe in case of the immune-system. On the con trary, curcumin is a section of our daily food behavior and its use in large quantities from ancient time has already proved it is a safe product. Actually, since curcumin choose ably induces apoptosis in highly proliferating cells, death is significantly more pronounced in tumefaction cells than normal ones. Report from our laboratory has shown that anticancer dose of curcumin arrests non-malignant cells in G0 phase reversibly but does not induce apoptosis in them. Further studies unmasked this phytochemical shields T cells of the cancer bearer from cancer together with chemotherapeutic agent induced apoptosis. The cornerstone of this differential regulation may be related to its differential effects on normal and neoplastic cell cycles since deregulation of some aspects of cell cycle regu latory equipment can get uncontrolled proliferation and therefore neoplastic transformations.